Skip to content

Transversus Thoracic Muscle Plane Combined With Pectoral Nerves Block for Breast Cancer Surgery

Quality of Recovery Scores in Transversus Thoracic Muscle Plane Combined With Pectoral Nerves Block Versus Pectoral Nerves Block for Breast Cancer Surgery: a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05448638
Enrollment
116
Registered
2022-07-07
Start date
2022-07-12
Completion date
2023-08-05
Last updated
2023-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Brief summary

This is a prospective, randomized, controlled trial for evaluating the efficacy of addition of transversus thoracic muscle plane block to pectoral nerves block versus pectoral nerves block for quality of recovery scores in breast cancer surgery.

Detailed description

The pectoral nerves (PECS) block cannot block the most internal mammary region, whereas a transversus thoracic muscle plane (TTP) block can. The combination of PECS and TTP blocks may be suitable for breast cancer surgery. We studied patients undergoing breast cancer surgery to assess whether the combination of PECS and TTP blocks provides better postoperative recovery than PECS block alone.

Interventions

PROCEDUREthe combination of transversus thoracic muscle plane and pectoral nerves blocks

For the pectoral nerves block, 0.375% ropivacaine , 10ml was injected between the pectoralis major and pectoralis minor and 20 ml above the serratus anterior muscle. For the transversus thoracic muscle plane block, ropivacaine 0.375%,15ml was injected between the transversus thoracic muscle and the internal intercostal muscle.

PROCEDUREthe pectoral nerves block only

For the pectoral nerves block, 0.375% ropivacaine , 10ml was injected between the pectoralis major and pectoralis minor and 20 ml above the serratus anterior muscle.

Sponsors

Zhejiang Cancer Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* female, 18-80 years of age * American Society of Anesthesiologists physical status I-III * patients having elective unilateral breast cancer surgery

Exclusion criteria

* contraindication to nerve block * inability to understand or communicate with research personnel * chronic use of opioids or nonsteroidal anti-inflammatory drugs * pregnancy

Design outcomes

Primary

MeasureTime frameDescription
the quality of recovery-15 questionnaire (QoR-15)at 24 hours after surgeryThe QoR-15 is a validated short-form postoperative quality of recovery score. Fifteen questions assess five domains of patient health-related quality of life: pain; comfort; physical independence; psychological support; and emotional state. Each question uses an 11-point rating scale, in which the maximum score is 150, denoting excellent recovery. 1. Able to breathe easily 2. Been able to enjoy food 3. Feeling rested 4. Have had a good sleep 5. Able to look after personal toilet and hygiene unaided 6. Able to communicate with family or friends 7. Getting support from hospital doctors and nurses 8. Able to return to work or usual home activities 9. Feeling comfortable and in control 10. Having a feeling of general well-being 11. Moderate pain 12. Severe pain 13. Nausea or vomiting 14. Feeling worried or anxious 15. Feeling sad or depressed

Secondary

MeasureTime frameDescription
NRS score for rest and coughing painat 1, 6, 24, 48 hours after surgeryPostoperative pain at rest and during coughing was assessed by NRS score with a range of 0 to 10 (0=no pain, 10=the worst possible pain)
consumption of opioid converted to IV morphine equivalentsduring 24 hours after surgeryopioids given postoperatively converted to IV morphine equivalents
the incidence of postoperative hypotensionduring 48 hours after surgeryAdverse reactions related to opioid
the incidence of nausea and vomitingduring 48 hours after surgeryAdverse reactions related to opioid
the incidence of pruritusduring 48 hours after surgeryAdverse reactions related to opioid
the incidence of respiratory depressionduring 48 hours after surgeryAdverse reactions related to opioid
postoperative hospital stay in daysthrough study completion, an average of 5-7 daysThe time from operation to discharge
intra-operative opioid requirementsthrough the anesthesia process, an average of 1.5-2.5hopioids given intra-operatively
the block-related outcomesthrough study completion, an average of 5-7 daysthe incidence of block-related complications (accidental intravascular injection, local anaesthetic systemic toxicity, haematoma and pneumothorax); and incidence of patient-reported transient neurological complications (paraesthesia or sensory deficit)
the Brief Pain Inventoryat 3 months after surgery.The Brief Pain Inventory instrument assesses 2 domains: pain and pain-related interference with physical and emotional functioning. 1. pain at its worst in the last 24 hours 2. pain at least in the last 24 hours 3. describe your pain on average 4. how much pain do you have right now 5. interference with general activity 6. interference with working ability 7. interference with work 8. interference with mood 9. interference with relations with other people 10. interference with sleep 11. interference with enjoyment of life
time to urethral catheter removal in hoursthrough study completion, an average of 24-36 hoursTime tourethral catheter removal after surgery

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026